Stockholm - Delayed Quote SEK

Fluicell AB (publ) (FLUI.ST)

11.50
-0.20
(-1.71%)
At close: May 9 at 5:29:42 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,556
3,338
3,251
2,602
4,635
Cost of Revenue
1,453
1,600
663
715
988
Gross Profit
103
1,738
2,588
1,887
3,647
Operating Expense
22,203
28,617
24,314
23,582
20,673
Operating Income
-22,100
-26,879
-21,726
-21,695
-17,026
Net Non Operating Interest Income Expense
484
849
311
2
-564
Pretax Income
-22,140
-26,554
-21,606
-21,693
-17,590
Tax Provision
0
0
0
--
--
Net Income Common Stockholders
-22,140
-26,554
-21,606
-21,693
-17,590
Diluted NI Available to Com Stockholders
-22,140
-26,554
-21,606
-21,693
-17,590
Basic EPS
0.42
-0.23
-0.21
-0.38
-0.31
Diluted EPS
0.42
-0.23
-0.21
-0.38
-0.31
Basic Average Shares
479,024.48
117,042.16
105,320.60
57,606.27
57,606.27
Diluted Average Shares
479,024.48
117,042.16
105,320.60
57,606.27
57,606.27
Total Operating Income as Reported
-22,100
-26,879
-21,726
-21,695
-17,026
Total Expenses
23,656
30,217
24,977
24,297
21,661
Net Income from Continuing & Discontinued Operation
-22,140
-26,554
-21,606
-21,693
-17,590
Normalized Income
-22,140
-26,554
-21,606
-21,693
-17,590
Interest Income
604
879
358
29
0
Interest Expense
--
30
47
27
564
Net Interest Income
484
849
311
2
-564
EBIT
-21,728
-26,524
-21,559
-21,666
-17,026
EBITDA
-21,256
-25,914
-20,839
-21,078
-16,421
Reconciled Cost of Revenue
1,453
1,600
663
715
988
Reconciled Depreciation
472
610
720
588
605
Net Income from Continuing Operation Net Minority Interest
-22,140
-26,554
-21,606
-21,693
-17,590
Normalized EBITDA
-21,256
-25,914
-20,839
-21,078
-16,421
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 4/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
 
SCOL.ST Scandion Oncology A/S
0.0188
+3.30%
 
KAN.ST Kancera AB (publ)
1.0880
+0.37%
 
ATORX.ST Alligator Bioscience AB (publ)
4.1500
+4.56%
 
DBP-B.ST Double Bond Pharmaceutical Int.
0.3750
-8.31%
 
ALPS Alpine Summit Energy Partners,
0.1425
0.00%
 
APTA.ST Aptahem AB (publ)
0.8020
+0.25%
 
QUIA.ST Quia Pharma AB (publ)
0.0089
-8.25%
 
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0936
+1.30%
 
NANECH.ST NanoEcho AB
0.1158
+7.22%